Barclays Starts China Medical Technologies (CMED) at Overweight
CMED Hot Sheet
Rating Summary:2 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Barclays initiates coverage on China Medical Technologies (NASDAQ: CMED) with an Overweight. PT $4.82.
For an analyst ratings summary and ratings history on China Medical Technologies click here. For more ratings news on China Medical Technologies click here.
Shares of China Medical Technologies closed at $2.84 yesterday, with a 52 week range of $2.32-$13.98.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
For an analyst ratings summary and ratings history on China Medical Technologies click here. For more ratings news on China Medical Technologies click here.
Shares of China Medical Technologies closed at $2.84 yesterday, with a 52 week range of $2.32-$13.98.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- UPDATE: Capstone Starts Facebook (FB) at Hold as Premium Multiple Not Justified
- Nomura Securities Maintains a 'Neutral' on Tiffany & Co. (TIF); Cutting Estimates and Price Target
- Goldman Sachs Boosts Numbers on PVH Corp (PVH) After Q1 Beat
Create E-mail Alert Related Categories
New CoverageRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
